Nationwide Shortage of Albuterol Inhalers and Off-Label Use in COVID-19 Patients

被引：5
|
作者：
Hendeles, Leslie [1 ,2 ]
Prabhakaran, Sreekala [2 ]
机构：
[1] Univ Florida, Coll Pharm, Gainesville, FL USA
[2] Univ Florida, Dept Pediat, Gainesville, FL USA
来源：
PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY | 2020年 / 33卷 / 04期
关键词：
albuterol; COVID-19; HFA MDI; drug shortages;
D O I：
10.1089/ped.2020.1300
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
The surge in COVID-19 cases during the 2020 Spring led to a nationwide shortage of albuterol inhalers. As a new surge has begun, shortages may make it difficult for patients with obstructive lung disease, including children with asthma, to obtain refills. Since there is no evidence that albuterol relieves symptoms in COVID-19 patients with respiratory symptoms not caused by bronchospasm, it is reasonable for clinicians to not prescribe it for COVID-19 patients unless they also have asthma or chronic obstructive pulmonary disease.
引用
收藏
页码：216 / 219
页数：4
相关论文
共 50 条
  • [1] Observational study on off-label use of tocilizumab in patients with severe COVID-19
    Albertini, Laetitia
    Soletchnik, Mickael
    Razurel, Anais
    Cohen, Johana
    Bidegain, Frederic
    Fauvelle, Francis
    Safrano, Geoffroy
    Piquet, Jacques
    Maurer, Cyril
    Goldgran-Toledano, Dany
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (01) : 22 - 27
  • [2] ADRs due to off-label use of hydroxychloroquine for COVID-19
    Reactions Weekly, 2022, 1907 (1) : 3 - 3
  • [3] Evaluating interest in off-label use of disinfectants for COVID-19
    Rivera, Jessica Malaty
    Gupta, Shagun
    Ramjee, Divya
    El Hayek, Ghinwa Y.
    El Amiri, Nisrine
    Desai, Angel N.
    Majumder, Maimuna S.
    LANCET DIGITAL HEALTH, 2020, 2 (11): : E564 - E566
  • [4] Multiple drugsPancytopenia, COVID-19 and off-label use: case report
    Reactions Weekly, 2020, 1831 (1) : 209 - 209
  • [5] Recommendations for the so-called off-label use of medicinal products in COVID-19 patients
    Sustek, P.
    Holcapek, T.
    Solc, M.
    ANESTEZIOLOGIE A INTENZIVNI MEDICINA, 2020, 31 (03): : 119 - 123
  • [6] Dexamethasone/rituximabWorsening of COVID-19 pneumonia and off-label use: case report
    Reactions Weekly, 2022, 1929 (1) : 248 - 248
  • [7] Multiple drugsLack of efficacy and off-label use in COVID-19: case report
    Reactions Weekly, 2022, 1914 (1) : 317 - 317
  • [8] Pediatric Off-Label Use of Covid-19 Vaccines: Ethical and Legal Considerations
    Lanphier, Elizabeth
    Fyfe, Shannon
    HASTINGS CENTER REPORT, 2021, 51 (06) : 27 - 32
  • [9] COVID-19 vaccine/rituximabLack of efficacy and off-label use: case report
    Reactions Weekly, 2023, 1943 (1) : 237 - 237
  • [10] Prednisolone/RemdesivirMaxillary mucormycosis and off-label use in COVID-19: case report
    Reactions Weekly, 2025, 2045 (1) : 360 - 360
12345